| Development of potential inhibitors for human T-lymphotropic virus type I integrase enzyme: a molecular modeling approach M Jalili-Nik, A Soltani, SI Hashemy, H Rafatpanah, SA Rezaee, A Gorji, ... Current Computer-Aided Drug Design 20 (1), 72-86, 2024 | 1 | 2024 |
| Determination of Normal Range of Acylcarnitine in Neonatal Dried Blood Spots using LC-MS/MS J Sadeq Abdulridha, B Mashkani, A Alaei, M Boskabadi, A Varasteh, ... Reports of Biochemistry and Molecular Biology 12, 522-529, 2024 | | 2024 |
| Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy B Mashkani, M Jalili Nik, SA Rezaee, R Boostani Expert Review of Neurotherapeutics 23 (12), 1233-1248, 2023 | | 2023 |
| The in vitro pro-inflammatory functions of the SP/NK1R System in prostate cancer: a focus on nuclear factor-kappa B (NF-κB) and its pro-inflammatory target genes S Ebrahimi, B Erfani, A Alalikhan, H Ghorbani, M Farzadnia, AR Afshari, ... Applied Biochemistry and Biotechnology 195 (12), 7796-7807, 2023 | 4 | 2023 |
| Rigosertib is more potent than wortmannin and rapamycin against adult T‐cell leukemia‐lymphoma M Ghorbanzadeh Neghab, M Jalili‐Nik, A Soltani, AR Afshari, ... BioFactors 49 (6), 1174-1188, 2023 | 1 | 2023 |
| Fenugreek seed extract regulates human umbilical vein endothelial cell angiogenesis and proliferation via the PI3K/Akt/cyclin D1 pathway S Safarpour, F Mirzavi, F Rahmani, F Forouzanfar, HR Sadeghnia, ... Alternatives to Laboratory Animals 51 (4), 249-257, 2023 | 1 | 2023 |
| Rigosertib is more potent than wortmannin and rapamycin against adult T-cell leukemia-lymphoma. M Jalili-Nik, A Soltani, AR Afshari, SM Hassanian, H Rafatpanah, ... Biofactors (Oxford, England), 2023 | | 2023 |
| Molecular insight into the study of adult T-cell leukemia/lymphoma (ATLL): Ten-year studies on HTLV-1 associated diseases in an endemic region F Ashrafi, M Rahimzada, M Parandi, A Mirhosseini, B Mashkani, ... Gene 847, 146885, 2022 | 1 | 2022 |
| Bee venom induces anti-tumor effects in HT-29 colon cancer cells through regulation of cell proliferation and apoptosis H Saghi, F Mirzavi, AR Afshari, M Jalili-Nik, B Mashkani, M Soukhtanloo Biologia 77 (12), 3595-3602, 2022 | 3 | 2022 |
| Challenges of expressing recombinant human tissue factor as a secreted protein in Pichia pastoris M Jalili-Nik, M Soukhtanloo, M Mojarrad, MH Sadeghian, B Mashkani Preparative Biochemistry & Biotechnology 52 (9), 1001-1007, 2022 | | 2022 |
| Glutathione reductase system changes in htlv-1 infected patients S Ehtiati, M Youssefi, H Rafatpanah, B Mashkani, M Khadem-Rezaiyan, ... Virusdisease 33 (1), 32-38, 2022 | 1 | 2022 |
| PD-1 and PD-L1 inhibitors foster the progression of adult T-cell Leukemia/Lymphoma M Jalili-Nik, A Soltani, B Mashkani, H Rafatpanah, SI Hashemy International Immunopharmacology 98, 107870, 2021 | 16 | 2021 |
| The Level of Mesenchymal-Epithelial Transition Autophosphorylation is Correlated with Esophageal Squamous Cell Carcinoma Migration N Taghehchian, M Moghbeli, B Mashkani, MR Abbaszadegan Iranian Biomedical Journal 25 (4), 243, 2021 | | 2021 |
| Application of molecular docking for the development of improved HIV-1 reverse transcriptase inhibitors A Soltani, SI Hashemy, FZ Avval, H Rafatpanah, SA Rezaee, R Griffith, ... Current Computer-Aided Drug Design 17 (4), 538-549, 2021 | 1 | 2021 |
| Comparison of the percentage of NRBC/100 WBC in early onset sepsis and non-infectious premature infants H Boskabadi, MH Sadeghian, B Meshkani, M Zakerihamidi Инфекция и иммунитет 11 (6), 1089-1094, 2021 | | 2021 |
| Interleukin-6 as A Prognostic Biomarker in Perinatal Asphyxia H Boskabadi, G Maamouri, M Zakerihamidi, F Bagheri, B Mashkani, ... Iranian journal of child neurology 15 (3), 119, 2021 | 2 | 2021 |
| Protective effects of BiP inducer X (BIX) against diabetic cardiomyopathy in rats G Idari, P Karimi, S Ghaffari, SI Hashemy, B Mashkani Canadian Journal of Physiology and Pharmacology 99 (6), 644-653, 2021 | 2 | 2021 |
| Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression F Mohammadi, H Javid, AR Afshari, B Mashkani, SI Hashemy Molecular biology reports 47, 4263-4272, 2020 | 43 | 2020 |
| Designing a multifunctional staphylokinase variant (SAK-2RGD-TTI) with appropriate thrombolytic activity in vitro H Faraji, F Soltani, M Ramezani, HR Sadeghnia, R Nedaeinia, ... Biotechnology letters 42, 103-114, 2020 | 2 | 2020 |
| Bacterial staphylokinase as a promising third-generation drug in the treatment for vascular occlusion R Nedaeinia, H Faraji, SH Javanmard, GA Ferns, M Ghayour-Mobarhan, ... Molecular Biology Reports 47, 819-841, 2020 | 30 | 2020 |
Hamid R. SadeghniaProfessor of Pharmacology, Mashhad University of Medical Sciences (MUMS)在 mums.ac.ir 的电子邮件经过验证
